Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

Ítems similars

• Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.
  per: Patick, A K, et al.
  Publicat: (1995)
• Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication.
  per: Deminie, C A, et al.
  Publicat: (1996)
• Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.
  per: Bechtold, C M, et al.
  Publicat: (1995)
• Potentiation of the stavudine anti-human immunodeficiency virus activity by 5-fluorouracil.
  per: Gong, Y F, et al.
  Publicat: (1996)
• Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor.
  per: Lin, P F, et al.
  Publicat: (1996)